![]() |
|
|
Vol. 282, Issue 3, 1408-1417, 1997
Department of Pharmacology (C.A.F., G.L.W.),
Graduate
Program in Neuroscience (G.L.W.), University of Minnesota,
Minneapolis, Minnesota
The mechanistic similarity between acutely and chronically induced
morphine tolerance has been previously proposed but remains largely
unexplored. Our experiments examined the modulation of acutely induced
tolerance to spinally administered morphine by agonists that affect the
N-methyl-D-aspartate receptor and nitric oxide synthase
systems. Antinociception was detected via the hot water (52.5°C) tail
flick test in mice. Intrathecal pretreatment with morphine (40 nmol)
produced a 9.6-fold rightward shift in the morphine dose-response
curve. This shift confirmed the induction of acute spinal morphine
tolerance. Intrathecal copretreatment with the receptor antagonists
(competitive and noncompetitive, respectively) dizolcipine (MK801, 3 nmol) or LY235959 (4 pmol) and morphine [40 nmol, intrathecally
(i.t.)] attenuated acute tolerance to morphine measured 8 hr later. A
60-min pretreatment of 7-nitroindazole (6 nmol, i.t.), a selective
neuronal NOS inhibitor, followed by administration of morphine (40 nmol, i.t.) blocked the induction of morphine tolerance. Intrathecal
copretreatment with morphine (40 nmol, i.t.) and agmatine (4 nmol,
i.t.), an imidazoline1 receptor agonist and putative nitric
oxide synthase inhibitor, almost completely abolished acute spinal
morphine tolerance. The results of these experiments agree with
previous reports using models of chronically induced
morphine tolerance. This evidence supports the proposal that the
mechanisms responsible for acute morphine tolerance parallel those
underlying chronic morphine tolerance. This study attests to the
powerful predictive value of acute induction as a model
for morphine tolerance.
This article has been cited by other articles:
![]() |
J. C. Roberts, B. M. Grocholski, K. F. Kitto, and C. A. Fairbanks Pharmacodynamic and Pharmacokinetic Studies of Agmatine after Spinal Administration in the Mouse J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 1226 - 1233. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Horvath, G. Kekesi, I. Dobos, W. Klimscha, and G. Benedek Long-Term Changes in the Antinociceptive Potency of Morphine or Dexmedetomidine After a Single Treatment Anesth. Analg., September 1, 2005; 101(3): 812 - 818. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. N. Johnston, E. D. Milligan, J. Wieseler-Frank, M. G. Frank, V. Zapata, J. Campisi, S. Langer, D. Martin, P. Green, M. Fleshner, et al. A Role for Proinflammatory Cytokines and Fractalkine in Analgesia, Tolerance, and Subsequent Pain Facilitation Induced by Chronic Intrathecal Morphine J. Neurosci., August 18, 2004; 24(33): 7353 - 7365. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Kekesi, I. Dobos, G. Benedek, and G. Horvath The Antinociceptive Potencies and Interactions of Endogenous Ligands During Continuous Intrathecal Administration: Adenosine, Agmatine, and Endomorphin-1 Anesth. Analg., February 1, 2004; 98(2): 420 - 426. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xu, Y. Gu, G.-Y. Xu, P. Wu, G.-W. Li, and L.-Y. M. Huang Adeno-associated viral transfer of opioid receptor gene to primary sensory neurons: A strategy to increase opioid antinociception PNAS, May 13, 2003; 100(10): 6204 - 6209. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Bohn, R. J. Lefkowitz, and M. G. Caron Differential Mechanisms of Morphine Antinociceptive Tolerance Revealed in beta Arrestin-2 Knock-Out Mice J. Neurosci., December 1, 2002; 22(23): 10494 - 10500. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. I. Cortinez, V. Brandes, H. R. Munoz, M. E. Guerrero, and M. Mur No clinical evidence of acute opioid tolerance after remifentanil-based anaesthesia Br. J. Anaesth., December 1, 2001; 87(6): 866 - 869. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Eilers, L. A. Philip, P. E. Bickler, W. R. McKay, and M. A. Schumacher The Reversal of Fentanyl-Induced Tolerance by Administration of ""Small-Dose"" Ketamine Anesth. Analg., July 1, 2001; 93(1): 213 - 214. [Full Text] [PDF] |
||||
![]() |
S. J. Park, C. Y. Chiang, J. W. Hu, and B. J. Sessle Neuroplasticity Induced by Tooth Pulp Stimulation in Trigeminal Subnucleus Oralis Involves NMDA Receptor Mechanisms J Neurophysiol, May 1, 2001; 85(5): 1836 - 1846. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Demady, S. Jianmongkol, J. L. Vuletich, A. T. Bender, and Y. Osawa Agmatine Enhances the NADPH Oxidase Activity of Neuronal NO Synthase and Leads to Oxidative Inactivation of the Enzyme Mol. Pharmacol., January 1, 2001; 59(1): 24 - 29. [Abstract] [Full Text] |
||||
![]() |
C. A. Fairbanks, K. L. Schreiber, K. L. Brewer, C.-G. Yu, L. S. Stone, K. F. Kitto, H. O. Nguyen, B. M. Grocholski, D. W. Shoeman, L. J. Kehl, et al. Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury PNAS, September 12, 2000; 97(19): 10584 - 10589. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Kissin, C. A. Bright, and E. L. Bradley Jr. Acute Tolerance to Continuously Infused Alfentanil: The Role of Cholecystokinin and N-Methyl-D-Aspartate-Nitric Oxide Systems Anesth. Analg., July 1, 2000; 91(1): 110 - 116. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Buerkle, E. Pogatzki, M. Pauser, C. Bantel, G. Brodner, T. Mollhoff, and H. Van Aken Experimental Arthritis in the Rat Does Not Alter the Analgesic Potency of Intrathecal or Intraarticular Morphine Anesth. Analg., August 1, 1999; 89(2): 403 - 403. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Fairbanks and G. L. Wilcox Moxonidine, a Selective alpha 2-Adrenergic and Imidazoline Receptor Agonist, Produces Spinal Antinociception in Mice J. Pharmacol. Exp. Ther., July 1, 1999; 290(1): 403 - 412. [Abstract] [Full Text] |
||||
![]() |
C. A. Fairbanks and G. L. Wilcox Spinal Antinociceptive Synergism between Morphine and Clonidine Persists in Mice Made Acutely or Chronically Tolerant to Morphine J. Pharmacol. Exp. Ther., March 1, 1999; 288(3): 1107 - 1116. [Abstract] [Full Text] |
||||